1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine | 107232-60-0

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷
• 英文名称: 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine
• 英文别名: 4-amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-phenylpyrimidin-2-one
• CAS: 107232-60-0
• 化学式: C₁₅H₁₆FN₃O₄
• 分子量: 321.308
• InChiKey: OUUDGZZYJIHGIY-GFQSEFKGSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  108
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine 在 磷酸三乙酯 、 三氯氧磷 作用下， 反应 8.0h， 生成 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine 5'-monophosphate
  参考文献：
  名称：

  Derivatives of 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenyluracil and 5-Benzyluracil. Synthesis and Biological Properties

  摘要：

  A number of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil and -cytosine nucleosides substituted at the 5 position with a nitrophenyl or nitrobenzyl group were synthesized from 5-phenyl- and 5-benzyluracil via condensation of the fluorinated sugar, followed by nitration. The corresponding amino analogues were also prepared by reduction of the nitro nucleosides. The uracil nucleosides were converted into the corresponding cytosine nucleosides by way of the triazole intermediates. None of these nucleosides exhibited significant activity against herpes simplex virus type 1 in Vero cells. However, cytosine nucleosides containing the o-nitrophenyl, p-nitrophenyl, p-nitrobenzyl or p-aminobenzyl substituent were found to be toxic (even at 1 mu M) to uninfected Vero cells, although they were essentially nontoxic in HL-60 cells. The 5'-monophosphates of the uracil nucleosides were inhibitors of the reaction catalyzed by purified Ehrlich ascites carcinoma thymidylate synthase, the 5-phenyluracil nucleotides causing a strong inhibition, competitive vs dUMP, described by the K-i value of 0.01 mu M.

  DOI：

  10.1080/15257779408013228
• 作为产物：
  描述：

  1,3-di-O-acetyl-5-O-benzoyl-2-deoxy-2-fluoro-D-arabinofuranose 在 吡啶 、 1H-1,2,4-三唑 、 甲醇 、 ammonium hydroxide 、 氨 、 氢溴酸 、 三氯氧磷 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 乙腈 为溶剂， 反应 177.5h， 生成 1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenylcytosine
  参考文献：
  名称：

  Derivatives of 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenyluracil and 5-Benzyluracil. Synthesis and Biological Properties

  摘要：

  A number of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil and -cytosine nucleosides substituted at the 5 position with a nitrophenyl or nitrobenzyl group were synthesized from 5-phenyl- and 5-benzyluracil via condensation of the fluorinated sugar, followed by nitration. The corresponding amino analogues were also prepared by reduction of the nitro nucleosides. The uracil nucleosides were converted into the corresponding cytosine nucleosides by way of the triazole intermediates. None of these nucleosides exhibited significant activity against herpes simplex virus type 1 in Vero cells. However, cytosine nucleosides containing the o-nitrophenyl, p-nitrophenyl, p-nitrobenzyl or p-aminobenzyl substituent were found to be toxic (even at 1 mu M) to uninfected Vero cells, although they were essentially nontoxic in HL-60 cells. The 5'-monophosphates of the uracil nucleosides were inhibitors of the reaction catalyzed by purified Ehrlich ascites carcinoma thymidylate synthase, the 5-phenyluracil nucleotides causing a strong inhibition, competitive vs dUMP, described by the K-i value of 0.01 mu M.

  DOI：

  10.1080/15257779408013228

文献信息

• 5-Substituted 1-(2'-deoxy-2'-substituted-beta-D-arabinofuranosyl) pyrimidine nucleosides and pharmaceutical compositions containing them
  申请人：Sloan-Kettering Institute For Cancer Research

  公开号：EP0010205A1

  公开（公告）日：1980-04-30

  1. Pyrimidine nucleosides exhibiting anti-viral and anti-tumor effects have the formula wherein A is OR', SR', NR3R4 or NHacyl wherein R' and R' are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralkyl, or aryl; NHacyl is alkanoyl or aroyl amide; B is oxygen or sulfur; X is halogen, alkylsulfonyl or arylsulfonyl; Y is halogen, amino, monoalkyl- or monoaralkylamino, dialkylamino, aminomethyl, hydroxymethyl, lower alkyl, aryl, aralkyl, vinyl and substituted vinyl or ethynyl and substituted ethynyl; Z is methyne or nitrogen; R1 and R2 are the same or different and are hydrogen acyl or aroyl.

  1.具有抗病毒和抗肿瘤作用的嘧啶核苷的化学式为 其中 A是OR'、SR'、NR3R4或NHacyl，其中R'和R'相同或不同，并且是氢、1至7个碳原子的低级烷基、芳基或芳基； NHacyl 是烷酰基或芳基酰胺； B 是氧或硫； X 是卤素、烷基磺酰基或芳基磺酰基； Y 是卤素、氨基、单烷基或单芳基氨基、二烷基氨基、氨甲基、羟甲基、低级烷基、芳基、芳烷基、乙烯基和取代乙烯基或乙炔基和取代乙炔基； Z 是甲基或氮； R1 和 R2 相同或不同，并且是氢酰基或芳基。
• US4211773A
  申请人：——

  公开号：US4211773A

  公开（公告）日：1980-07-08
• US4594339A
  申请人：——

  公开号：US4594339A

  公开（公告）日：1986-06-10
• Derivatives of 1-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)-5-phenyluracil and 5-Benzyluracil. Synthesis and Biological Properties
  作者：Krzysztof Dziewiszek、Raymond F. Schinazi、Ting-Chao Chou、Tsann-Long Su、Jolanta M. Dzik、Wojciech Rode、Kyoichi A. Watanabe

  DOI：10.1080/15257779408013228

  日期：1994.3

  A number of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil and -cytosine nucleosides substituted at the 5 position with a nitrophenyl or nitrobenzyl group were synthesized from 5-phenyl- and 5-benzyluracil via condensation of the fluorinated sugar, followed by nitration. The corresponding amino analogues were also prepared by reduction of the nitro nucleosides. The uracil nucleosides were converted into the corresponding cytosine nucleosides by way of the triazole intermediates. None of these nucleosides exhibited significant activity against herpes simplex virus type 1 in Vero cells. However, cytosine nucleosides containing the o-nitrophenyl, p-nitrophenyl, p-nitrobenzyl or p-aminobenzyl substituent were found to be toxic (even at 1 mu M) to uninfected Vero cells, although they were essentially nontoxic in HL-60 cells. The 5'-monophosphates of the uracil nucleosides were inhibitors of the reaction catalyzed by purified Ehrlich ascites carcinoma thymidylate synthase, the 5-phenyluracil nucleotides causing a strong inhibition, competitive vs dUMP, described by the K-i value of 0.01 mu M.